Richard Roeper was the longtime nationally syndicated film and TV columnist for the Chicago Sun-Times. He currently does reviews for ABC-7 TV in Chicago, and on his podcast, “The Richard Roeper ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...